{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T12:56:45Z","timestamp":1791377805095,"version":"4.3.2"},"reference-count":24,"publisher":"Ovid Technologies (Wolters Kluwer Health)","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"abstract":"<jats:sec>\n                    <jats:title\/>\n                    <jats:p>Prostate cancer remains a major cause of cancer-related mortality among men worldwide; however, it remains challenging to predict disease progression in individuals. While numerous tools attempt to forecast the likelihood of developing the cancer, fewer studies focus specifically on mortality prediction using population-scale clinical datasets. UK Biobank data were used to develop population-scale predictive models of prostate cancer mortality. The study assessed medical records, blood work, physical measurements, and genetic information of approximately 167 000 males aged 50 and above. A feedforward neural network was compared with logistic regression to determine their effectiveness. The neural network demonstrated substantially stronger predictive performance than logistic regression, achieving a receiver operating characteristic\u2013area under the curve of 0.767 compared with 0.633 and a precision\u2013recall\u2013area under the curve of 0.271 compared with 0.153, respectively. The analysis revealed that age and genetics were the primary influencing factors. Decision curve analysis demonstrated minimal net benefit across clinically relevant thresholds. These findings support the utility of multimodal risk modeling while highlighting challenges in clinical translation.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/cej.0000000000001037","type":"journal-article","created":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T17:00:56Z","timestamp":1790269256000},"update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Predicting prostate cancer mortality using UK Biobank data: a multimodal machine learning approach"],"prefix":"10.1097","author":[{"given":"Shwas","family":"Churi","sequence":"first","affiliation":[{"name":"School of Infection & Immunity"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bodhayan","family":"Prasad","sequence":"additional","affiliation":[{"name":"School of Cancer Sciences"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bhautesh","family":"Jani","sequence":"additional","affiliation":[{"name":"School of Health & Wellbeing, University of Glasgow, Glasgow, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2026,9,25]]},"reference":[{"issue":"Suppl 5","key":"R1-20261007","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1016\/j.eursup.2006.05.003","article-title":"The PCPT: new findings, new insights, and clinical implications for the prevention of prostate cancer.","volume":"5","author":"Akduman","year":"2006","journal-title":"Eur Urol Suppl"},{"key":"R2-20261007","doi-asserted-by":"crossref","first-page":"e034661","DOI":"10.1136\/bmjopen-2019-034661","article-title":"Prediction models for prostate cancer to be used in the primary care setting: a systematic review.","volume":"10","author":"Aladwani","year":"2020","journal-title":"BMJ Open"},{"key":"R3-20261007","first-page":"1466","article-title":"PRSice-2: polygenicrisk score software for biobank-scale data.","volume":"35","author":"Choi","year":"2019","journal-title":"Bioinformatics"},{"key":"R5-20261007","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1186\/s12957-025-03733-1","article-title":"Global burden of prostate cancer: age-period-cohort analysis from 1990 to 2021 and projections until 2040.","volume":"23","author":"Chu","year":"2025","journal-title":"World J Surg Oncol"},{"key":"R6-20261007","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1002\/pros.24537","article-title":"Development and validation of a simple prostate cancer risk prediction model based on age, family history, and polygenic risk.","volume":"83","author":"Dite","year":"2023","journal-title":"Prostate"},{"key":"R7-20261007","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.soncn.2011.07.002","article-title":"Prostate cancer overview.","volume":"27","author":"Dunn","year":"2011","journal-title":"Semin Oncol Nurs"},{"key":"R8-20261007","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1093\/aje\/kwx246","article-title":"Comparison of sociodemographic and health-related characteristics of UK biobank participants with those of the general population.","volume":"186","author":"Fry","year":"2017","journal-title":"Am J Epidemiol"},{"key":"R9-20261007","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.eururo.2014.09.022","article-title":"Prognostic factors for survival in noncastrate metastatic prostate cancer: validation of the glass model and development of a novel simplified prognostic model.","volume":"68","author":"Gravis","year":"2015","journal-title":"Eur Urol"},{"key":"R10-20261007","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1016\/S0140-6736(03)12713-4","article-title":"Prostate cancer epidemiology.","volume":"361","author":"Gr\u00f6nberg","year":"2003","journal-title":"Lancet"},{"key":"R11-20261007","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1093\/jnci\/djt280","article-title":"Prognostic model predicting metastatic castration-resistant prostate cancer survival in men treated with second-line chemotherapy.","volume":"105","author":"Halabi","year":"2013","journal-title":"J Natl Cancer Inst"},{"issue":"13 Suppl","key":"R12-20261007","doi-asserted-by":"crossref","first-page":"3085","DOI":"10.1002\/cncr.24357","article-title":"Techniques and predictive models to improve prostate cancer detection.","volume":"115","author":"Herman","year":"2009","journal-title":"Cancer"},{"key":"R13-20261007","doi-asserted-by":"crossref","first-page":"e364","DOI":"10.3399\/bjgp20X714137","article-title":"Predicting the risk of prostate cancer in asymptomatic men: a cohort study to develop and validate a novel algorithm.","volume":"71","author":"Hippisley-Cox","year":"2021","journal-title":"Br J Gen Pract"},{"key":"R14-20261007","doi-asserted-by":"crossref","first-page":"2013","DOI":"10.1056\/NEJMcp1103642","article-title":"Clinical practice. Screening for prostate cancer.","volume":"365","author":"Hoffman","year":"2011","journal-title":"N Engl J Med"},{"key":"R15-20261007","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1080\/07357907.2017.1406496","article-title":"Prostate cancer probability prediction by machine learning technique.","volume":"35","author":"Jovi\u0107","year":"2017","journal-title":"Cancer Invest"},{"key":"R16-20261007","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1007\/s00345-015-1691-4","article-title":"PREDICT: model for prediction of survival in localized prostate cancer.","volume":"34","author":"Kerkmeijer","year":"2016","journal-title":"World J Urol"},{"key":"R17-20261007","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.4143\/crt.2017.484","article-title":"Lifestyle risk prediction model for prostate cancer in a Korean population.","volume":"50","author":"Kim","year":"2018","journal-title":"Cancer Res Treat"},{"key":"R18-20261007","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1093\/annonc\/mdu525","article-title":"Do prostate cancer risk models improve the predictive accuracy of PSA screening? A meta-analysis.","volume":"26","author":"Louie","year":"2015","journal-title":"Ann Oncol"},{"key":"R19-20261007","first-page":"4765","article-title":"A unified approach to interpreting model predictions.","volume":"30","author":"Lundberg","year":"2017","journal-title":"Adv Neural Inf Process Syst"},{"key":"R20-20261007","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.3390\/cancers14061589","article-title":"The Barcelona Predictive Model of clinically significant prostate cancer.","volume":"14","author":"Morote","year":"2022","journal-title":"Cancers (Basel)"},{"key":"R21-20261007","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1007\/s00345-018-2574-2","article-title":"Prognostic models for predicting overall survival in metastatic castration-resistant prostate cancer: a systematic review.","volume":"38","author":"Pinart","year":"2020","journal-title":"World J Urol"},{"key":"R22-20261007","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/j.eururo.2024.11.013","article-title":"Recent patterns and trends in global prostate cancer incidence and mortality: an update.","volume":"87","author":"Schafer","year":"2025","journal-title":"Eur Urol"},{"key":"R23-20261007","doi-asserted-by":"crossref","first-page":"3075","DOI":"10.1002\/cncr.23908","article-title":"An updated catalog of prostate cancer predictive tools.","volume":"113","author":"Shariat","year":"2008","journal-title":"Cancer"},{"key":"R24-20261007","doi-asserted-by":"crossref","first-page":"3972","DOI":"10.1200\/JCO.2002.11.021","article-title":"Nomogram for overall survival of patients with progressive metastatic prostate cancer after castration.","volume":"20","author":"Smaletz","year":"2002","journal-title":"J Clin Oncol"},{"key":"R25-20261007","doi-asserted-by":"crossref","first-page":"e1001779","DOI":"10.1371\/journal.pmed.1001779","article-title":"UK biobank: an open access resource for identifying the causes of a wide range of complex diseases of middle and old age.","volume":"12","author":"Sudlow","year":"2015","journal-title":"PLoS Med"}],"container-title":["European Journal of Cancer Prevention"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/CEJ.0000000000001037","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T12:00:16Z","timestamp":1791374416000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1097\/CEJ.0000000000001037"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,25]]},"references-count":24,"URL":"https:\/\/doi.org\/10.1097\/cej.0000000000001037","relation":{},"ISSN":["0959-8278","1473-5709"],"issn-type":[{"value":"0959-8278","type":"print"},{"value":"1473-5709","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,25]]},"assertion":[{"value":"2026-05-22","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-08-03","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}